野生動物健康市場－全球產業規模、佔有率、趨勢、機會和預測：按動物類型、產品、給藥途徑、最終用途、地區和競爭情況分類，2021-2031年

全球野生動物健康市場預計將從 2025 年的 134.6 億美元大幅成長至 2031 年的 215.4 億美元，複合年成長率為 8.15%。

此領域涵蓋圈養和野生動物族群疾病管理所需關鍵工具的開發和應用，例如診斷方法、疫苗、藥物和監測系統。市場成長趨勢的強勁動力主要得益於全球範圍內「同一健康」框架的實施，該框架將動物健康和人類健康相結合，並強調了保護生物多樣性免受嚴重疾病爆發破壞性影響的嚴格保護義務。

儘管成長指標強勁，但該產業在監測和進入地理位置偏遠地區的野生動物方面面臨著巨大的後勤挑戰，這常常導致漏報和對新興病原體的反應遲緩。世界動物衛生組織（OIE）的數據顯示，2025年1月至6月期間，58個國家和地區共報告了7062起野生動物疾病疫情和14757例指定病例，凸顯了這項挑戰。這些統計數據表明，在營運和地理環境複雜的情況下，維持有效的全球監測活動至關重要且難度高。

市場促進因素

推動市場擴張的主要動力是感染疾病和新興感染疾病的日益蔓延，這迫切需要診斷工具和監測通訊協定的快速發展。隨著病原體跨越通用屏障傳播，野生動物健康專家必須利用先進的監測系統，在病毒攜帶者影響人類健康或牲畜之前，識別出野生族群中的病毒攜帶者。歐洲食品安全局 (EFSA) 的一份報告強調了這一需求，該報告指出，僅在 2025 年 6 月至 9 月的三個月內，歐洲 15 個國家就檢測到了 156 例高致病性禽流感病毒病例。感染率的廣泛激增促使各國政府實施專門的獸醫措施和防治方案，直接提升了市場收入。

此外，政府增加對保育計畫的撥款和津貼，為高成本的野生動物健康干預措施提供了至關重要的資金來源。公共部門的投資對於鼓勵治療方法至關重要，而這些物種往往被私人投資者忽視。例如，美國農業部動植物衛生服務局於2025年6月向州和部落政府撥款1,200萬美元，用於防治慢性消耗性疾病。明尼蘇達大學報告稱，到2025年，這種疾病已蔓延至36個州，因此，此類資金有助於應對日益嚴重的生態學威脅，而持續投入資金用於購置診斷設備和進行長期管理工作也至關重要。

市場挑戰

全球野生動物健康市場面臨巨大的成長障礙，這主要是由於在崎嶇偏遠地區進行野生動物監測工作存在許多後勤挑戰。這些地理障礙造成了高成本的營運瓶頸，限制了必要的監測基礎設施和診斷工具（例如野外檢測套組和疫苗）的廣泛部署。當獸醫團隊無法抵達極地地區、山區和茂密叢林中與世隔絕的動物種群時，數據收集就變成了間歇性的而非連續性的，這使得企業無法獲得與長期疾病控制舉措相關的穩定收入來源。

這些物流限制的嚴重性體現在追蹤廣闊且難以到達地區快速傳播的病原體的難度。例如，世界動物衛生組織（OIE）記錄顯示，2024年有55個國家和地區爆發了非家禽物種的高致病性禽流感疫情，顯示監測方面有顯著缺口。因此，物流摩擦導致可控疫情的發現延誤，削弱了野生動物衛生措施的即時商業性應用和有效性，並阻礙了市場擴張。

市場趨勢

先進的口服疫苗遞送機制的研發正在改變疾病管理方式，無需個體捕捉即可在攜帶病毒的動物群體中實現群體免疫。這項創新技術顯著降低了與傳統捕捉和注射方法相關的安全風險和營運成本，使獸醫團隊能夠控制生活在廣闊且難以到達地區的野生食肉動物體內的病毒傳播。透過空中和地面投放誘餌，衛生組織可以建立群體免疫緩衝區，防止病原體的擴散。 2025年8月，美國農業部在緬因州的一個計畫制定了計劃，擬投放約71.3萬個口服狂犬病疫苗誘餌，以系統地控制當地野生動物體內的病毒傳播。

同時，環境DNA（eDNA）作為一種非侵入性採樣技術，正從根本上改變監測工作流程。它能夠透過檢測水、土壤和植物中存在的遺傳痕跡來識別病原體和隱存物種。這項技術克服了物理採集和目視檢查的局限性，為在傳統監測難以進行的複雜生態系統中快速繪製宿主儲存和生物多樣性分佈圖提供了一種有效方法。這種分子生物學方法的高效性為解決後勤瓶頸問題提供了一個可擴展的方案。例如，根據美國國家野生動物聯合會2024年9月發布的報告，研究人員利用eDNA技術在新澤西州的一片森林中，僅用一天時間就識別出了棲息在400英畝（約162公頃）森林中的約90%的哺乳動物物種。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球野生動物健康市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 動物種類（哺乳類、鳥類、魚類、爬蟲類、兩棲類）
  • 依產品類別（藥品、設備和耗材）
  • 給藥途徑（口服、注射、其他）
  • 依用途（動物園、野生動物保護區、野生動物救援中心、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美野生動物健康市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲野生動物健康市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區野生動物健康市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲野生動物健康市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲野生動物健康市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球野生動物健康市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Boehringer Ingelheim International GmbH
• NexGen Pharmaceuticals LLC
• Virbac SA
• Dong Bang Co., Ltd.
• Pneu-Dart Inc.
• DANiNJECT
• Genia Inc.
• Wedgewood Pharmacy LLC
• The Pet Apothecary
• Taylors Pharmacy LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Wildlife Health Market is projected to expand significantly, growing from USD 13.46 Billion in 2025 to USD 21.54 Billion by 2031, representing a Compound Annual Growth Rate (CAGR) of 8.15%. This sector comprises the development and deployment of essential tools such as diagnostics, vaccines, pharmaceuticals, and surveillance systems aimed at managing diseases in both captive and free-ranging wild animal populations. The market's upward trajectory is robustly underpinned by the global implementation of the One Health framework, which integrates animal and human well-being, alongside rigorous conservation mandates designed to shield biodiversity from the devastating impacts of severe disease outbreaks.

Despite these strong growth indicators, the industry faces a considerable obstacle regarding the logistical difficulties of monitoring and accessing wildlife in isolated geographic areas, which frequently leads to underreporting and delayed responses to emerging pathogens. Highlighting this challenge, data from the World Organisation for Animal Health indicates that between January and June 2025, 58 countries and territories reported 7,062 outbreaks and 14,757 cases of listed diseases in wildlife. These statistics emphasize the critical, yet arduous, nature of maintaining effective global surveillance efforts in the face of operational and geographical complexities.

Market Driver

A primary engine for market expansion is the escalating prevalence of zoonotic and emerging infectious diseases, which demands the rapid advancement of diagnostic utilities and surveillance protocols. As pathogens increasingly cross species barriers, wildlife health professionals must utilize sophisticated monitoring systems to identify viral reservoirs in free-ranging populations before they affect human health or livestock, a necessity underscored by the European Food Safety Authority's report of 156 highly pathogenic avian influenza virus detections across 15 European countries between June and September 2025 alone. This surge in widespread infection rates drives governments to acquire specialized veterinary countermeasures and containment solutions, directly boosting market revenue.

Furthermore, the increase in government funding and grants for conservation programs supplies the vital financial capital needed to support high-cost wildlife health interventions. Public sector investment is crucial for motivating institutions to create treatments for non-commercial species that are often overlooked by private investors, as evidenced by the USDA Animal and Plant Health Inspection Service's allocation of $12 million in June 2025 to state and tribal governments for controlling chronic wasting disease. With the University of Minnesota reporting the disease in 36 states in 2025, such funding addresses a growing ecological threat and necessitates sustained spending on diagnostic procurement and long-term management.

Market Challenge

The Global Wildlife Health Market encounters substantial growth barriers due to the logistical challenges inherent in accessing and monitoring wildlife within rugged and remote environments. These geographical obstacles create high-cost operational bottlenecks that restrict the widespread deployment of necessary surveillance infrastructures and diagnostics, such as field testing kits and vaccines. When veterinary teams are unable to physically reach isolated animal populations in polar regions, mountainous terrains, or dense forests, data collection becomes sporadic rather than continuous, preventing companies from securing consistent revenue streams tied to long-term disease management initiatives.

The severity of these logistical constraints is clearly demonstrated by the difficulty in tracking rapidly spreading pathogens across vast and inaccessible territories. For instance, the World Organisation for Animal Health recorded High Pathogenicity Avian Influenza outbreaks in non-poultry species across 55 countries and territories in 2024, illustrating the massive scale of the surveillance gap. Consequently, the market struggles to expand because logistical friction delays the detection of addressable outbreaks, thereby diminishing the immediate commercial application and effectiveness of wildlife health interventions.

Market Trends

The development of advanced oral vaccine delivery mechanisms is transforming disease management by facilitating the mass immunization of reservoir populations without requiring individual capture. This innovation significantly lowers the safety risks and operational costs associated with traditional trap-and-inject techniques, enabling veterinary teams to curb viral circulation in free-ranging carnivores across extensive, inaccessible areas. By employing aerial and ground-based bait distribution, health agencies can establish herd immunity buffers to prevent pathogen spillover, as demonstrated by the USDA's August 2025 project in Maine, which scheduled the distribution of approximately 713,000 oral rabies vaccine baits to systematically control the virus in local wildlife.

Concurrently, the application of environmental DNA (eDNA) for non-invasive sampling is fundamentally reshaping surveillance workflows by enabling the detection of disease vectors and cryptic species through genetic traces found in water, soil, or foliage. This technology circumvents the limitations of physical trapping and visual spotting, providing a rapid method to map host reservoirs and biodiversity in rugged ecosystems where traditional monitoring often falls short. The efficiency of this molecular approach offers a scalable solution to logistical bottlenecks; for example, a September 2024 report by the National Wildlife Federation noted that researchers using eDNA in a New Jersey forest successfully identified an estimated 90 percent of mammal species across 400 acres in just one day.

Key Market Players

• Boehringer Ingelheim International GmbH
• NexGen Pharmaceuticals LLC
• Virbac S.A.
• Dong Bang Co., Ltd.
• Pneu-Dart Inc.
• DANiNJECT
• Genia Inc.
• Wedgewood Pharmacy LLC
• The Pet Apothecary
• Taylors Pharmacy LLC

Report Scope

In this report, the Global Wildlife Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wildlife Health Market, By Animal Type

• Mammals
• Birds
• Fish
• Reptiles
• Amphibians

Wildlife Health Market, By Product

• Medicine
• Equipment & Consumables

Wildlife Health Market, By Route of Administration

• Oral
• Injectables
• Others

Wildlife Health Market, By End-Use

• Zoos
• Wildlife Sanctuaries
• Wildlife Rescue & Rehab Centers
• Others

Wildlife Health Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Wildlife Health Market.

Available Customizations:

Global Wildlife Health Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wildlife Health Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Mammals, Birds, Fish, Reptiles, Amphibians)
  • 5.2.2. By Product (Medicine, Equipment & Consumables)
  • 5.2.3. By Route of Administration (Oral, Injectables, Others)
  • 5.2.4. By End-Use (Zoos, Wildlife Sanctuaries, Wildlife Rescue & Rehab Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Wildlife Health Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Product
  • 6.2.3. By Route of Administration
  • 6.2.4. By End-Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Wildlife Health Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Route of Administration
      • 6.3.1.2.4. By End-Use
  • 6.3.2. Canada Wildlife Health Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Route of Administration
      • 6.3.2.2.4. By End-Use
  • 6.3.3. Mexico Wildlife Health Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Route of Administration
      • 6.3.3.2.4. By End-Use

7. Europe Wildlife Health Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Product
  • 7.2.3. By Route of Administration
  • 7.2.4. By End-Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Wildlife Health Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Route of Administration
      • 7.3.1.2.4. By End-Use
  • 7.3.2. France Wildlife Health Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Route of Administration
      • 7.3.2.2.4. By End-Use
  • 7.3.3. United Kingdom Wildlife Health Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Route of Administration
      • 7.3.3.2.4. By End-Use
  • 7.3.4. Italy Wildlife Health Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Route of Administration
      • 7.3.4.2.4. By End-Use
  • 7.3.5. Spain Wildlife Health Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Route of Administration
      • 7.3.5.2.4. By End-Use

8. Asia Pacific Wildlife Health Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Product
  • 8.2.3. By Route of Administration
  • 8.2.4. By End-Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Wildlife Health Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Route of Administration
      • 8.3.1.2.4. By End-Use
  • 8.3.2. India Wildlife Health Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Route of Administration
      • 8.3.2.2.4. By End-Use
  • 8.3.3. Japan Wildlife Health Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Route of Administration
      • 8.3.3.2.4. By End-Use
  • 8.3.4. South Korea Wildlife Health Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Route of Administration
      • 8.3.4.2.4. By End-Use
  • 8.3.5. Australia Wildlife Health Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Route of Administration
      • 8.3.5.2.4. By End-Use

9. Middle East & Africa Wildlife Health Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Product
  • 9.2.3. By Route of Administration
  • 9.2.4. By End-Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Wildlife Health Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Route of Administration
      • 9.3.1.2.4. By End-Use
  • 9.3.2. UAE Wildlife Health Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Route of Administration
      • 9.3.2.2.4. By End-Use
  • 9.3.3. South Africa Wildlife Health Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Route of Administration
      • 9.3.3.2.4. By End-Use

10. South America Wildlife Health Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Product
  • 10.2.3. By Route of Administration
  • 10.2.4. By End-Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Wildlife Health Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Route of Administration
      • 10.3.1.2.4. By End-Use
  • 10.3.2. Colombia Wildlife Health Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Route of Administration
      • 10.3.2.2.4. By End-Use
  • 10.3.3. Argentina Wildlife Health Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Route of Administration
      • 10.3.3.2.4. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Wildlife Health Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boehringer Ingelheim International GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. NexGen Pharmaceuticals LLC
• 15.3. Virbac S.A.
• 15.4. Dong Bang Co., Ltd.
• 15.5. Pneu-Dart Inc.
• 15.6. DANiNJECT
• 15.7. Genia Inc.
• 15.8. Wedgewood Pharmacy LLC
• 15.9. The Pet Apothecary
• 15.10. Taylors Pharmacy LLC

16. Strategic Recommendations

17. About Us & Disclaimer